Introduction
Contrast-induced acute kidney injury (CI-AKI), alternatively referred to as contrast-induced nephropathy (CIN), ranks as the third most common cause of AKI resulting from medical interventions.1 As an iatrogenic disease, CI-AKI can be defined as an elevation in serum creatinine (Scr) by at least 0.5 mg/dl or 25% from baseline in the first 48 hours after contrast administration, without other reasons for renal function impairment.2 CI-AKI is a main complication caused by percutaneous coronary intervention (PCI), characterized by acute or sub-acute renal function deterioration owing to exposure to iodinated contrast medium that is linked to raised morbidity and mortality.3 CI-AKI incidence stands out in patients with higher age, systemic arterial hypertension, diabetes mellitus, the volume of contrast…